Overview

Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study will gather information on the safety and efficacy of patients with rheumatoid arthritis (RA) who are starting treatment with infliximab for the first time. Patients will be treated in the usual manner according to local guidelines and normal clinical practice.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Infliximab